The role of resistance to acetylsalicylic acid in patients with ischemic stroke

Purpose: The aim of the study was to review the current data from the literature on resistance to acetylsalicylic acid in patients with ischemic stroke, in particular its incidence, etiological mechanisms, diagnostic tests, its impact on the prognosis for patients who have suffered the stroke and the use of alternative antiplatelet therapies. Views: Acetylsalicylic acid is the most commonly used antiplatelet drug in the treatment and prophylaxis of patients with a diagnosis of ischemic stroke. It inhibits the activation and aggregation of platelets, playing an important role in the etiopathogenesis of ischemic stroke. In many patients, the reduced sensitivity of platelets to acetylsalicylic acid contributes to the ineffectiveness of the treatment. Platelet reactivity tests allow for the estimation of the laboratory resistance to aspirin and determine its impact on the prognosis of patients with ischemic stroke. Conclusions: The incidence of resistance to acetylsalicylic acid is common (5-65%) and has a complex, multifactorial aetiology, which significantly inhibits its therapeutic effect. Aspirin resistance worsens the ischemic stroke patients’ prognosis, both early and long-term, as has a negative impact on their clinical and functional status, mortality, size of ischemic focus and also for the tendency towards the recurrence of cerebrovascular incidents. Alternative therapies are recommended for patients with resistance to acetylsalicylic acid. Further research is required so as to enable aspirin-resistant patients to take advantage of optimized antiplatelet treatment, the effectiveness of which is a priority among this group of patients.

• Publication year

  2019

• Venue

  Postępy Psychiatrii i Neurologii

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.5114/ppn.2019.92487
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• 2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association

  2018cited by this paper
• Aspirin resistance are associated with long-term recurrent stroke events after ischaemic stroke.

  2017cited by this paper
• Aspirin Resistance in Acute Ischemic Non-cardioembolic Stroke: Frequency and Clinical Study

  2017influential reference
• Efficacy and safety of ticagrelor versus aspirin in acute stroke or transient ischaemic attack of atherosclerotic origin: a subgroup analysis of SOCRATES, a randomised, double-blind, controlled trial.

  2017cited by this paper
• Biochemical aspirin resistance is associated with increased stroke severity and infarct volumes in ischemic stroke patients

  2017cited by this paper
• The Interplay between Stroke Severity, Antiplatelet Use, and Aspirin Resistance in Ischemic Stroke.

  2016cited by this paper
• Aspirin resistance is associated with increased stroke severity and infarct volume

  2016cited by this paper
• Prevention of Stroke with Ticagrelor in Patients with Prior Myocardial Infarction: Insights from PEGASUS-TIMI 54 (Prevention of Cardiovascular Events in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin-Thrombolysis in Myocardial Infarction 54)

  2016cited by this paper
• Global , regional , and national age – sex specifi c all-cause and cause-specifi c mortality for 240 causes of death , 1990 – 2013 : a systematic analysis for the Global Burden of Disease Study 2013

  2015cited by this paper
• Aspirin Resistance in the Acute Stages of Acute Ischemic Stroke Is Associated with the Development of New Ischemic Lesions

  2015cited by this paper
• Switching from aspirin to clopidogrel in patients with aspirin resistance after an ischemic stroke. Is it a good solution?

  2014cited by this paper
• HEART DISEASE AND STROKE STATISTICS–2014 UPDATE: A REPORT FROM THE AMERICAN HEART ASSOCIATION

  2014cited by this paper
• Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association

  2013cited by this paper
• Association of aspirin resistance with increased stroke severity and infarct size.

  2013cited by this paper
• An Updated Definition of Stroke for the 21st Century: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association

  2013cited by this paper
• Biochemical aspirin resistance in stroke patients - a cross-sectional single centre study

  2013cited by this paper
• Aspirin and Clopidogrel for Prevention of Ischemic Stroke

  2013cited by this paper
• Relationship between acute stroke outcome, aspirin resistance, and humoral factors

  2012cited by this paper
• Effects of clopidogrel added to aspirin in patients with recent lacunar stroke.

  2012cited by this paper
• Aspirin resistance in patients with acute ischemic stroke

  2011influential reference
• Laboratoryjna ocena odpowiedzi na leczenie kwasem acetylosalicylowym (ASA) u pacjentów w ostrej fazie udaru niedokrwiennego mózgu – zastosowanie agregometrii przepływowej (PFA-100) i impedancyjnej (Multiplate)

  2011cited by this paper
• Biochemical Aspirin Resistance and Recurrent Lesions in Patients with Acute Ischemic Stroke

  2010cited by this paper
• Methods for the measurement of platelet function.

  2009cited by this paper
• Aspirin Resistance is More Common in Lacunar Strokes than Embolic Strokes and is Related to Stroke Severity

  2008cited by this paper
• Aspirin Responsiveness in Acute Brain Ischaemia: Association with Stroke Severity and Clinical Outcome

  2008cited by this paper
• Aspirin resistance.

  2007influential reference
• Mechanisms of action and targets for actual and future antiplatelet drugs.

  2006cited by this paper
• Screening for Aspirin Responsiveness After Transient Ischemic Attack and Stroke: Comparison of 2 Point-of-Care Platelet Function Tests With Optical Aggregometry

  2005influential reference
• Increased protein glycation in diabetes mellitus is associated with decreased aspirin-mediated protein acetylation and reduced sensitivity of blood platelets to aspirin

  2005cited by this paper
• Link between Platelet Activity and Outcomes after an Ischemic Stroke

  2005cited by this paper
• Resistance to Aspirin in Patients After Coronary Artery Bypass Grafting Is Transient: Impact on the Monitoring of Aspirin Antiplatelet Therapy

  2005cited by this paper
• The antithrombotic profile of aspirin. Aspirin resistance, or simply failure?

  2004cited by this paper
• Antiplatelet Effect of Aspirin in Patients With Cerebrovascular Disease

  2003cited by this paper
• American Heart Association.

  1958cited by this paper
• Vascular Health and Risk Management Dovepress Platelet Function Tests: a Comparative Review

  year unknowninfluential reference

• Platelet function‐guided antiplatelet therapy in stroke prevention

  2021cites this paper